Because NRF2 activity is associated with reductions in redox stress and anti-inflammatory effects, it has been implicated as a potential therapeutic target in a range of vascular, metabolic and neurodegenerative diseases, and the prevention of certain cancers. The gene discussed is NFE2L2; the disease is cancer.